Complete molecular remission in a polycythaemia vera patient 12 years after discontinuation of interferon-alpha

Annals of Hematology

Volumn 90, Issue 2, 2011, Pages 233-234

  Murphy, Philip T ^b   McPherson, Suzanne ^a   Langabeer, Stephen E ^a  

^a ST JAMES S HOSPITAL   (Ireland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; HEMOGLOBIN; IRON; JANUS KINASE 2; RETICULIN;

ADULT; ALLELE; BLOOD ANALYSIS; BONE MARROW BIOPSY; CASE REPORT; CELL HYPERPLASIA; DNA EXTRACTION; DRUG RESPONSE; DRUG WITHDRAWAL; ERYTHROCYTE COUNT; ERYTHROID CELL; ERYTHROPOIESIS; FATIGUE; FOLLOW UP; GENE REPRESSION; HEMOGLOBIN BLOOD LEVEL; HETEROZYGOTE DETECTION; HUMAN; HUMAN TISSUE; IMMUNOMODULATION; LETTER; MALE; MEAN CORPUSCULAR VOLUME; MEGAKARYOPOIESIS; MOLECULAR CLONING; MUTATIONAL ANALYSIS; MYELOPOIESIS; PHLEBOTOMY; POLYCYTHEMIA VERA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REMISSION; SPLENOMEGALY; THROMBOCYTE COUNT;

HUMANS; INTERFERON-ALPHA; JANUS KINASE 2; MALE; MUTATION; POLYCYTHEMIA VERA; REMISSION INDUCTION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78751585321     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-010-0993-2     Document Type: Letter

References (12)

1. TS Larsen OW Bjerrum N Pallisgaard MT Andersen MB Moller HC Hasselbalch 2008 Sustained major molecular response on interferon alpha-2b in two patients with polycythemia vera Ann Hematol 87 847 850 1:STN:280:DC%2BD1crktVensQ%3D%3D 10.1007/s00277-008-0498-4 18481066
2. HS Gilbert 1998 Long term treatment of myeloproliferative disease with interferon-alpha-2b. Feasibility and efficacy Cancer 83 1205 1213 1:CAS:528:DyaK1cXmtlegsrk%3D 10.1002/(SICI)1097-0142(19980915)83:6<1205::AID- CNCR21>3.0.CO;2-8 9740087
3. J-J Kiladjian B Cassinat S Chevret P Turlure N Cambier M Roussel S Bellucci B Grandchamp C Chomienne P Fenaux 2008 Pegylated-interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera Blood 112 3065 3072 1:CAS:528:DC%2BD1cXht1OmtbfE 10.1182/blood-2008-03-143537 18650451
4. A Quintas-Cardama H Kantarjian T Manshouri R Luthra Z Estrov S Pierce MA Richie G Borthakur M Konopleva J Cortes S Verstovsek 2009 Pegylated interferon alfa-2a yields high rates of hematologic and molecular response in patients with advanced essential thrombocythemia and polycythemia vera J Clin Oncol 27 5418 5424 1:CAS:528:DC%2BD1MXhsFKkt7vP 10.1200/JCO.2009.23.6075 19826111
5. A Chen J Prchal 2010 JAK2 kinase inhibitors and myeloproliferative disorders Curr Opin Hematol 17 110 116 1:CAS:528:DC%2BC3cXhs1yns7Y%3D 10.1097/MOH.0b013e3283366b91 20087176
6. EJ Baxter LM Scott PJ Campbell C East N Fourouclas S Swanton GS Vassiliou AJ Bench EM Boyd N Curtin MA Scott WN Erber The Cancer Genome Project AR Green 1995 Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders Lancet 365 1054 1061
7. TS Larsen N Pallisgaard MB Moller HC Hasselbalch 2008 Quantitative assessment of the JAK2 V617F allele burden: equivalent levels in peripheral blood and bone marrow Leukemia 22 194 195 1:CAS:528:DC%2BD1cXmsV2itQ%3D%3D 10.1038/sj.leu.2404861 17625603
8. G Barosi G Birgegard G Finazzi M Griesshammer C Harrison HC Hasselbalch JJ Kiladjian E Lengfelder MF McMullin F Passamonti JT Reilly AM Vannucchi T Barbui 2009 Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference Blood 113 4829 4833 1:CAS:528:DC%2BD1MXmslalsb8%3D 10.1182/blood-2008-09-176818 19278953
9. DH Cowan HA Messner N Jamal MT Aye RK Smiley 1994 Spontaneous remission of polycythemia vera: clinical and cell culture characteristics Am J Hematol 46 54 56 1:STN:280:DyaK2c3ktFWquw%3D%3D 10.1002/ajh.2830460110 8184876
10. C Steimle U Lehmann S Temerinac S Goerttler Ph H Kreipe G Meinhardt H Heimpel HL Pahl 2007 Biomarker analysis in polycythemia vera under interferon-alpha treatment: clonality, EEC, PRV-1, and JAK2 V617F Ann Hematol 86 239 244 1:CAS:528:DC%2BD2sXitVOlsbY%3D 10.1007/s00277-006-0214-1 17256145
11. GR Angstreich W Matsui CA Huff MS Vala J Barber AL Hawkins CA Griffin BD Smith RJ Jones 2005 Effects of imatinib and interferon on primitive chronic myeloid leukaemia progenitors Br J Haematol 130 373 381 1:CAS:528: DC%2BD2MXhtVWjsLjN 10.1111/j.1365-2141.2005.05606.x 16042686
12. Sacchi S, Cortes J, Kantarjian H, Talpaz M (1997-1998) Effects of interferon-alpha therapy on lymphocyte subpopulations in patients with chronic myeloid leukemia. Hematopathol Mol Hematol 11: 41-47